Healthcare: These Two Stocks Are On Different Paths, But Both Remain Risky

<p>The Motley Fool discusses how investors might want to think about Valeant Pharmaceuticals' share price tailspin and marijuana drugmaker GW Pharmaceuticals' skyrocketing valuation.</p>